Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Deepfake doctor videos boost heart patient adherence?

NCT ID NCT07210073

Disease control Sponsor: Keimyung University Dongsan Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether video education using deepfake technology—where an AI replicates the patient's own doctor's voice—could improve blood pressure monitoring and medication adherence in 218 adults with both ischemic heart disease and hypertension. Participants were randomly assigned to receive either the video education or standard care, and adherence was tracked over 30 days. The goal was to see if a personalized, low-cost intervention could help patients better manage their condition at home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Video education using deepfake technology
What this could lead to
If it works, this could offer a simple, low-cost way to help people with heart disease and high blood pressure better manage their condition at home.
What could go wrong
This is a small, completed study with 218 participants, so results may not apply to everyone. The intervention is behavioral, not a drug, so its impact on actual health outcomes may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

218 people

The number who actually took part.

Started

May 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older, both male and female, with a history of hypertension or who have taken antihypertensive medication at least once, satisfying one or more of the following ischemic heart disease conditions (PCI, CABG, CAD \>50% by CCT or CAG), or patients with a history of hypertension or currently taking antihypertensive medication. * Individuals who have voluntarily provided written consent to participate in this clinical trial. Exclusion Criteria: * SBP \< 90 mmHg or DBP \< 50 mmHg * Individuals intolerant to all antihypertensive medications * Patients with heart failure due to other causes, Pregnant women, those suspected of being pregnant, or those who are breastfeeding * Patients whom the investigator deems legally or mentally unfit to participate in the clinical trial * Patients who have participated in another clinical study involving investigational drugs within 4 weeks prior to screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension (HTN) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension (HTN) Ischemic heart disease

Contacts and locations

Locations

  • Keimyung University Dongsan Hospital

    Daegu, Daegu, 42601, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.